SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
91,500
-900 (-0.97%)
Last updated: Jun 26, 2025

SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 7.15 trillion as of June 27, 2025. Its market cap has increased by 10.53% in one year.

Market Cap
7.15T
Enterprise Value
7.03T
Revenue
578.00B
Ranking
n/a
PE Ratio
28.46
Stock Price
91,500.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.15T, a decrease of -28.11%. That is a compound annual growth rate of -6.40%.

History

DateMarket Cap% Change
Jun 27, 20257,150.00B-17.82%
Dec 30, 20248,700.60B10.66%
Dec 28, 20237,862.65B39.25%
Dec 29, 20225,646.39B-25.82%
Dec 30, 20217,612.05B-42.49%
Dec 30, 202013.23T33.07%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 71.46T
Celltrion 35.49T
ALTEOGEN 20.84T
Yuhan 7,640.71B
HLB Co., Ltd. 6,499.30B
PharmaResearch 4,992.23B
Peptron 4,741.01B
SK bioscience 3,973.32B
Market Cap Rankings